Agilent Technologies (Oligo GMP)

Boulder, CO · Frederick, CO
Find alternatives to Agilent Technologies (Oligo GMP) for Oligonucleotide →
Reagent / Material Supplier
1 confirmed programs · 1 sponsors · Last scored 2026-10-29
74.2
Signal Score
✓ FDA Inspections (2) ✓ Clinical Trials (1) ○ SEC Filings ○ Press ○ EMA GMP ○ MHRA GMP

Quick Facts: Agilent Technologies (Oligo GMP)

Signal Score
74.2/100 (as of 2026-10-29)
Quality Compliance
100.0/100
Headquarters
Boulder, CO · Frederick, CO
Modalities
Oligonucleotide
Active Programs
1 confirmed from ClinicalTrials.gov across 1 sponsors
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About Agilent Technologies (Oligo GMP)

Reagent/raw material supplier.

Signal Score & Pillar Breakdown

Quality Compliance 100.0
FDA Inspections2 on record
Warning Letters0
Last InspectionNo Action Indicated (NAI) (2026-05-06)
Operations 60.0
1 active programs across 1 sponsors
Modalities: Oligonucleotide
1 programs in advanced phases (Phase 2/3)
Source: ClinicalTrials.gov
1 active programs across 1 sponsors · Modalities: Oligonucleotide · 1 programs in advanced phases (Phase 2/3)
Programs 1
Sponsors1
ModalitiesOligonucleotide
1 active programs across 1 sponsors
Modalities: Oligonucleotide
1 programs in advanced phases (Phase 2/3)
Source: ClinicalTrials.gov facility matching
NCT02452697 Ph2 NK Cell Enriched DCIs w/wo RLR9 Agonist, DUK-CPG-001 From... PHASE2 Unknown
Source: ClinicalTrials.gov · Retrieved Nov 21, 2026
Financial Stability 68.0
Parent company: Agilent Technologies
Financial assessment: 68.0/100
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Parent company: Agilent Technologies
Financial assessment: 68.0/100
Capacity 53.0
1 manufacturing site: Boulder, CO
Modalities: Oligonucleotide
Capacity assessment: 53.0/100
Sites: Boulder, CO
Source: company profiles (manufacturing sites, modality breadth)
1 manufacturing site
1 manufacturing site: Boulder, CO
Modalities: Oligonucleotide
Capacity assessment: 53.0/100

Agilent Technologies (Oligo GMP) FDA Inspection History

2026-05
2025-06
NAI VAI OAI
Date Site Type 483 citations posted Classification
2026-05-06
Agilent Technologies Inc
Boulder, Colorado Facility-linked
Drug Quality Assurance Not posted No Action Indicated (NAI)
2025-06-18
Agilent Technologies Inc
Frederick, Colorado Facility-linked
Drug Quality Assurance Not posted No Action Indicated (NAI)
Source: FDA Data Dashboard · Retrieved Nov 21, 2026

Clinical Activity 1 studies

Source: ClinicalTrials.gov · Retrieved Nov 21, 2026

Hiring Activity Beta

Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No count for this company yet. The careers board we can read covers more than this business (100 postings on Nov 20, 2026), and we can't yet tell which of those roles belong to it. Why: the group's board only shows its ~100 newest postings across all units, so we can't separate this business's roles. We'd rather show no number than one that isn't really this company's.
Source: agilent.wd5.myworkdayjobs.com · Checked Nov 20, 2026

Frequently Asked Questions About Agilent Technologies (Oligo GMP)

How many FDA inspections does Agilent Technologies (Oligo GMP) have on record?
CDMO Signal tracks 2 FDA inspections for Agilent Technologies (Oligo GMP), sourced from the FDA inspection database. See the full inspection history above.
Has Agilent Technologies (Oligo GMP) received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Agilent Technologies (Oligo GMP).
How many clinical programs is Agilent Technologies (Oligo GMP) linked to?
Agilent Technologies (Oligo GMP) is associated with 1 clinical trial in CDMO Signal's ClinicalTrials.gov-sourced data.
What is Agilent Technologies (Oligo GMP)'s CDMO Signal Score?
Agilent Technologies (Oligo GMP) has a Signal Score of 74/100, based on quality, operations, financial stability, and capacity data.
Evaluating Agilent Technologies (Oligo GMP) for a manufacturing program?
Use the free AI matchmaker to compare Agilent Technologies (Oligo GMP) against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Oligonucleotide CDMOs →

Similar CDMOs

Ajinomoto Bio-Pharma Services
San Diego, CA · Osaka, JP
Signal Score: 83.5
Oligonucleotide, Biologics, AAV
Corden Pharma
Plankstadt, DE · Caponago, IT · Boulder, CO
Signal Score: 83.1
mRNA, Oligonucleotide, Biologics
Curia (RNA/Advanced)
Albany, NY · Albuquerque, NM
Signal Score: 79.5
mRNA, Oligonucleotide, Biologics
PolyPeptide Group
Torrance, CA · Strasbourg, FR · Malmo, SE
Signal Score: 77.4
Oligonucleotide
LGC Biosearch Technologies
Petaluma, CA · Middleton, WI
Signal Score: 63.0
Oligonucleotide

Compare Agilent Technologies (Oligo GMP) with another CDMO

Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.
Compare side-by-side
See two CDMOs' scoring, inspection history, and clinical footprint next to each other.
Open comparison →
Run a sourcing search
Describe your program's requirements — Signal matches CDMOs against FDA, EMA/MHRA, ClinicalTrials.gov and capacity signals.
Search for a CDMO →
Get updates on Agilent Technologies (Oligo GMP)
Get an email when a CDMO on this list has a new FDA inspection, GMP certificate, or scoring change.